Parathyroid hormone-related protein, its regulation of cartilage and bone development, and role in treating bone diseases

Physiological Reviews

Volumn 96, Issue 3, 2016, Pages 831-871

  John Martin, T ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; KARYOPHERIN BETA; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PARATHYROID HORMONE[1-34];

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BONE DEVELOPMENT; BONE DISEASE; BONE REMODELING; CALCIUM METABOLISM; CALCIUM TRANSPORT; CARTILAGE; CELL LINEAGE; CHONDRODYSPLASIA; CLONING; ENCHONDRAL OSSIFICATION; FETUS DEVELOPMENT; GENE CONTROL; GENE STRUCTURE; GLYCOSYLATION; HORMONAL REGULATION; HUMAN; HYPERCALCEMIA; NEOPLASM; NONHUMAN; NUCLEAR IMPORT; OSTEOBLAST; OSTEOPOROSIS; OSTEOSARCOMA; PLACENTAL TRANSFER; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN PURIFICATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; BONE DISEASES; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MOUSE; PHYSIOLOGY;

ANIMALS; BONE DEVELOPMENT; BONE DISEASES; CARTILAGE; HUMANS; MICE; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN;

EID: 84983785852     PISSN: 00319333     EISSN: 15221210     Source Type: Journal    
DOI: 10.1152/physrev.00031.2015     Document Type: Article

References (397)

1. Aarts MM, Davidson D, Corluka A, Petroulakis E, Guo J, Bringhurst FR, Galipeau J, Henderson JE. Parathyroid hormone-related protein promotes quiescence and survival of serum-deprived chondrocytes by inhibiting rRNA synthesis. J Biol Chem 276: 37934-37943, 2001.
2. Aarts MM, Levy D, He B, Stregger S, Chen T, Richard S, Henderson JE. Parathyroid hormone-related protein interacts with RNA. J Biol Chem 274: 4832-4838, 1999.
3. Aarts MM, Rix A, Guo J, Bringhurst R, Henderson JE. The nucleolar targeting signal (NTS) of parathyroid hormone related protein mediates endocytosis and nucleolar translocation. J Bone Miner Res 14: 1493-1503, 1999.
4. Albright F. Case Records of the Massachusetts General Hospital-Case 39061. N Engl J Med 225: 789-796, 1941.
5. Allgrove J, Adami S, Manning RM, O’Riordan JL. Cytochemical bioassay of parathyroid hormone in maternal and cord blood. Arch Dis Child 60: 110-115, 1985.
6. Allinson ET, Drucker DJ. Parathyroid hormone-like peptide shares features with members of the early response gene family: rapid induction by serum, growth factors, and cycloheximide. Cancer Res 52: 3103-3109, 1992.
7. Alonso V, de Gortazar AR, Ardura JA, Andrade-Zapata I, Alvarez-Arroyo MV, Esbrit P. Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2. J Cell Physiol 217: 717-727, 2008.
8. Amizuka N, Fukushi-Irie M, Sasaki T, Oda K, Ozawa H. Inefficient function of the signal sequence of PTHrP for targeting into the secretory pathway. Biochem Biophys Res Commun 273: 621-629, 2000.
9. Amizuka N, Karaplis AC, Henderson JE, Warshawsky H, Lipman ML, Matsuki Y, Ejiri S, Tanaka M, Izumi N, Ozawa H, Goltzman D. Haploinsufficiency of parathyroid hormone-related peptide (PTHrP) results in abnormal postnatal bone development. Dev Biol 175: 166-176, 1996.
10. Amizuka N, Warshawsky H, Henderson JE, Goltzman D, Karaplis AC. Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol 126: 1611-1623, 1994.
11. Ansari N, Ho P, Gooi J, Martin TJ, Sims NA. Osteocyte production of PTHrP is necessary for normal osteocyte differentiation and bone remodelling. J Bone Miner Res 26: S112, 2015.
12. Ardeshirpour L, Dumitru C, Dann P, Sterpka J, VanHouten J, Kim W, Kostenuik P, Wysolmerski J. OPG treatment prevents bone loss during lactation but does not affect milk production or maternal calcium metabolism. Endocrinology 156: 2762-2773, 2015.
13. Arlot M, Meunier PJ, Boivin G, Haddock L, Tamayo J, Correa-Rotter R, Jasqui S, Donley DW, Dalsky GP, Martin JS, Eriksen EF. Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters. J Bone Miner Res 20: 1244-1253, 2005.
14. Asa SL, Henderson J, Goltzman D, Drucker DJ. Parathyroid hormone-like peptide in normal and neoplastic human endocrine tissues. J Clin Endocrinol Metab 71: 1112-1118, 1990.
15. Atkins D, Hunt NH, Ingleton PM, Martin TJ. Rat osteogenic sarcoma cells: isolation and effects of hormones on the production of cyclic AMP and cyclic GMP. Endocrinology 101: 555-561, 1977.
16. Atkins D, Ibbotson KJ, Hillier K, Hunt NH, Hammonds JC, Martin TJ. Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture. Br J Cancer 36: 601-607, 1977.
17. Augustine M, Horwitz MJ. Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis. Curr Osteoporos Rep 11: 400-406, 2013.
18. Bacci G, Longhi A, Fagioli F, Briccoli A, Versari M, Picci P. Adjuvant and neoadjuvant chemotherapy for osteosarcoma of the extremities: 27 year experience at Rizzoli Institute, Italy. Eur J Cancer 41: 2836-2845, 2005.
19. Barden JA, Kemp BE. NMR solution structure of human parathyroid hormone(1-34). Biochemistry 32: 7126-7132, 1993.
20. Barden JA, Kemp BE. Stabilized NMR structure of the hypercalcemia of malignancy peptide PTHrP[Ala-26](1-34)amide. Biochim Biophys Acta 1208: 256-262, 1994.
21. Bastepe M, Weinstein LS, Ogata N, Kawaguchi H, Juppner H, Kronenberg HM, Chung UI. Stimulatory G protein directly regulates hypertrophic differentiation of growth plate cartilage in vivo. Proc Natl Acad Sci USA 101: 14794-14799, 2004.
22. Bauer W, Aub JC, Albright F. Studies of calcium phosphorus metabolism. A study of the bone trabeculae as a readily available source of calcium. J Exp Med 49: 145-162, 1929.
23. Behar V, Nakamoto C, Greenberg Z, Bisello A, Suva LJ, Rosenblatt M, Chorev M. Histidine at position 5 is the specificity "switch" between two parathyroid hormone receptor subtypes. Endocrinology 137: 4217-4224, 1996.
24. Belanger LF. Osteocytic osteolysis. Calcif Tissue Res 4: 1-12, 1969.
25. Benson RC Jr, Riggs BL, Pickard BM, Arnaud CD. Immunoreactive forms of circulating parathyroid hormone in primary and ectopic hyperparathyroidism. J Clin Invest 54: 175-181, 1974.
26. Beristain AG, Molyneux SD, Joshi PA, Pomroy NC, Di Grappa MA, Chang MC, Kirschner LS, Prive GG, Pujana MA, Khokha R. PKA signaling drives mammary tumorigenesis through Src. Oncogene 34: 1160-1173, 2015.
27. Berman SD, Calo E, Landman AS, Danielian PS, Miller ES, West JC, Fonhoue BD, Caron A, Bronson R, Bouxsein ML, Mukherjee S, Lees JA. Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc Natl Acad Sci USA 105: 11851-11856, 2008.
28. Berson SA, Yalow RS. Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma. Science 154: 907-909, 1966.
29. Betel D, Koppal A, Agius P, Sander C, Leslie C. Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol 11: R90, 2010.
30. Black DM, Greenspan SL, Ensrud KE, Palermo L, McGowan JA, Lang TF, Garnero P, Bouxsein ML, Bilezikian JP, Rosen CJ. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med 349: 1207-1215, 2003.
31. Black DM, Schafer AL. The search for the optimal anabolic osteoporosis therapy. J Bone Miner Res 28: 2263-2265, 2013.
32. Blomstrand S, Claesson I, Save-Soderbergh J. A case of lethal congenital dwarfism with accelerated skeletal maturation. Pediatr Radiol 15: 141-143, 1985.
33. Bonewald LF. The amazing osteocyte. J Bone Miner Res 26: 229-238, 2011.
34. Botella A, Rekik M, Delvaux M, Davicco MJ, Barlet JP, Frexinos J, Bueno L. Parathyroid hormone (PTH) and PTH-related peptide induce relaxation of smooth muscle cells from guinea pig ileum: interaction with vasoactive intestinal peptide receptors. Endocrinology 135: 2160-2167, 1994.
35. Brissenden JE, Ullrich A, Francke U. Human chromosomal mapping of genes for insulin-like growth factors I and II and epidermal growth factor. Nature 310: 781-784, 1984.
36. Brommage R, DeLuca HF. Regulation of bone mineral loss during lactation. Am J Physiol Endocrinol Metab 248: E182-E187, 1985.
37. Bruns ME, Ferguson JE, 2nd Bruns DE, Burton DW, Brandt DW, Juppner H, Segre GV, Deftos LJ. Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acid in human amnion and chorion-decidua: implications for secretion and function. Am J Obstet Gynecol 173: 739-746, 1995.
38. Buckle RM, McMillan M, Mallinson C. Ectopic secretion of parathyroid hormone by a renal adenocarcinoma in a patient with hypercalcaemia. Br Med J 4: 724-726, 1970.
39. Buenzli PR, Sims NA. Quantifying the osteocyte network in the human skeleton. Bone 75: 144-150, 2015.
40. Burgess TL, Kelly RB. Constitutive and regulated secretion of proteins. Annu Rev Cell Biol 3: 243-293, 1987.
41. Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP Jr, Olson BR,WuTL, Mitnick ME, Broadus AE, Stewart AF Olson BR, Wu TL, Mitnick ME, Broadus AE, Stewart AF. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med 322: 1106-1112, 1990.
42. Burtis WJ, Fodero JP, Gaich G, Debeyssey M, Stewart AF. Preliminary characterization of circulating amino- and carboxy-terminal fragments of parathyroid hormonerelated peptide in humoral hypercalcemia of malignancy. J Clin Endocrinol Metab 75: 1110-1114, 1992.
43. Burtis WJ,WuT, Bunch C, Wysolmerski JJ, Insogna KL, Weir EC, Broadus AE, Stewart AF. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase- stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem 262: 7151-7156, 1987.
44. Campos RV, Wang C, Drucker DJ. Regulation of parathyroid hormone-related peptide (PTHrP) gene transcription: cell- and tissue-specific promoter utilization mediated by multiple positive and negative cis-acting DNA elements. Mol Endocrinol 6: 1642-1652, 1992.
45. Canalis E, Giustina A, Bilezikian JP. Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357: 905-916, 2007.
46. Caplan RH, Beguin EA. Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation. Obstet Gynecol 76: 485-489, 1990.
47. Care AD, Abbas SK, Pickard DW, Barri M, Drinkhill M, Findlay JB, White IR, Caple IW. Stimulation of ovine placental transport of calcium and magnesium by mid-molecule fragments of human parathyroid hormone-related protein. Exp Physiol 75: 605-608, 1990.
48. Charbon GA. A rapid and selective vasodialtor effect of parathyroid hormone. Eur J Pharmacol 3: 275-278, 1968.
49. Charbon GA, Hulstaert PF. Augmentation of arterial hepatic and renal flow by extracted and synthetic parathyroid hormone. Endocrinology 96: 621-626, 1974.
50. Chen X, Macica C, Nasiri A, Judex S, Broadus AE. Mechanical regulation of PTHrP expression in entheses. Bone 41: 752-759, 2007.
51. Chen X, Macica CM, Ng KW, Broadus AE. Stretch-induced PTH-related protein gene expression in osteoblasts. J Bone Miner Res 20: 1454-1461, 2005.
52. Chen Z, Xu P, Barbier JR, Willick G, Ni F. Solution structure of the osteogenic 1-31 fragment of the human parathyroid hormone. Biochemistry 39: 12766-12777, 2000.
53. Chilco PJ, Leopold V, Zajac JD. Differential regulation of the parathyroid hormonerelated protein gene P1 and P3 promoters by cAMP. Mol Cell Endocrinol 138: 173-184, 1998.
54. Chung UI, Lanske B, Lee K, Li E, Kronenberg H. The parathyroid hormone/parathyroid hormone-related peptide receptor coordinates endochondral bone development by directly controlling chondrocyte differentiation. Proc Natl Acad Sci USA 95: 13030-13035, 1998.
55. Cingolani G, Bednenko J, Gillespie MT, Gerace L. Molecular basis for the recognition of a nonclassical nuclear localization signal by importin beta. Mol Cell 10: 1345-1353, 2002.
56. Conlan LA, Martin TJ, Gillespie MT. The COOH-terminus of parathyroid hormonerelated protein (PTHrP) interacts with beta-arrestin 1B. FEBS Lett 527: 71-75, 2002.
57. Cooper CW, Seitz PK, McPherson MB, Selvanayagam P, Rajaraman S. Effects of parathyroid hormonal peptides on the gut. Contrib Nephrol 91: 26-31, 1991.
58. Cornish J, Callon KE, Lin C, Xiao C, Moseley JM, Reid IR. Stimulation of osteoblast proliferation by C-terminal fragments of parathyroid hormone-related protein. J Bone Miner Res 14: 915-922, 1999.
59. Cornish J, Callon KE, Nicholson GC, Reid IR. Parathyroid hormone-related protein-(107-139) inhibits bone resorption in vivo. Endocrinology 138: 1299-1304, 1997.
60. Cramer SD, Chen Z, Peehl DM. Prostate specific antigen cleaves parathyroid hormone- related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts. J Urol 156: 526-531, 1996.
61. Daifotis AG, Weir EC, Dreyer BE, Broadus AE. Stretch-induced parathyroid hormone- related peptide gene expression in the rat uterus. J Biol Chem 267: 23455-23458, 1992.
62. Danks JA, D’Souza DG, Gunn HJ, Milley KM, Richardson SJ. Evolution of the parathyroid hormone family and skeletal formation pathways. Gen Comp Endocrinol 170: 79-91, 2011.
63. Danks JA, Devlin AJ, Ho PM, Diefenbach-Jagger H, Power DM, Canario A, Martin TJ, Ingleton PM. Parathyroid hormone-related protein is a factor in normal fish pituitary. Gen Comp Endocrinol 92: 201-212, 1993.
64. Danks JA, Ebeling PR, Hayman JA, Diefenbach-Jagger H, Collier FM, Grill V, Southby J, Moseley JM, Chou ST, Martin TJ. Immunohistochemical localization of parathyroid hormone-related protein in parathyroid adenoma and hyperplasia. J Pathol 161: 27-33, 1990.
65. Danks JA, Trivett MK, Power DM, Canario AV, Martin TJ, Ingleton PM. Parathyroid hormone-related protein in lower vertebrates. Clin Exp Pharmacol Physiol 25: 750-752, 1998.
66. De Castro LF, Lozano D, Portal-Nunez S, Maycas M, De la Fuente M, Caeiro JR, Esbrit P. Comparison of the skeletal effects induced by daily administration of PTHrP (1-36) and PTHrP (107-139) to ovariectomized mice. J Cell Physiol 227: 1752-1760, 2012.
67. De Gortazar AR, Alonso V, Alvarez-Arroyo MV, Esbrit P. Transient exposure to PTHrP (107-139) exerts anabolic effects through vascular endothelial growth factor receptor 2 in human osteoblastic cells in vitro. Calcif Tissue Int 79: 360-369, 2006.
68. De Lean A, Stadel JM, Lefkowitz RJ. A ternary complex model explains the agonistspecific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem 255: 7108-7117, 1980.
69. De Miguel F, Fiaschi-Taesch N, Lopez-Talavera JC, Takane KK, Massfelder T, Helwig JJ, Stewart AF. The C-terminal region of PTHrP, in addition to the nuclear localization signal, is essential for the intracrine stimulation of proliferation in vascular smooth muscle cells. Endocrinology 142: 4096-4105, 2001.
70. Dean T, Linglart A, Mahon MJ, Bastepe M, Juppner H, Potts JT Jr, Gardella TJ. Mechanisms of ligand binding to the parathyroid hormone (PTH)/PTH-related protein receptor: selectivity of a modified PTH(1-15) radioligand for GalphaS-coupled receptor conformations. Mol Endocrinol 20: 931-943, 2006.
71. Dean T, Vilardaga JP, Potts JT Jr, Gardella TJ. Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor. Mol Endocrinol 22: 156-166, 2008.
72. Delmas PD, Vergnaud P, Arlot ME, Pastoureau P, Meunier PJ, Nilssen MH. The anabolic effect of human PTH (1-34) on bone formation is blunted when bone resorption is inhibited by the bisphosphonate tiludronate-is activated resorption a prerequisite for the in vivo effect of PTH on formation in a remodeling system? Bone 16: 603-610, 1995.
73. Demiralp B, Chen HL, Koh AJ, Keller ET, McCauley LK. Anabolic actions of parathyroid hormone during bone growth are dependent on c-fos. Endocrinology 143: 4038-4047, 2002.
74. Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetic K, Muller R, Bilezikian J, Lindsay R. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study. J Bone Miner Res 16: 1846-1853, 2001.
75. Devlin AJ, Danks JA, Faulkner MK, Power DM, Canario AV, Martin TJ, Ingleton PM. Immunochemical detection of parathyroid hormone-related protein in the saccus vasculosus of a teleost fish. Gen Comp Endocrinol 101: 83-90, 1996.
76. Diefenbach-Jagger H, Brenner C, Kemp BE, Baron W, McLean J, Martin TJ, Moseley JM. Arg21 is the preferred kexin cleavage site in parathyroid-hormone-related protein. Eur J Biochem 229: 91-98, 1995.
77. Ditmer LS, Burton DW, Deftos LJ. Elimination of the carboxy-terminal sequences of parathyroid hormone-related protein 1-173 increases production and secretion of the truncated forms. Endocrinology 137: 1608-1617, 1996.
78. Dittmer J, Gitlin SD, Reid RL, Brady JN. Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotropic virus type I Tax1: evidence for the involvement of transcription factor Ets1. J Virol 67: 6087-6095, 1993.
79. Dittmer J, Pise-Masison CA, Clemens KE, Choi KS, Brady JN. Interaction of human T-cell lymphotropic virus type I Tax, Ets1, and Sp1 in transactivation of the PTHrP P2 promoter. J Biol Chem 272: 4953-4958, 1997.
80. Divieti P, Inomata N, Chapin K, Singh R, Juppner H, Bringhurst FR. Receptors for the carboxyl-terminal region of pth(1- 84) are highly expressed in osteocytic cells. Endocrinology 142: 916-925, 2001.
81. Donaghy AJ, Baxter RC. Insulin-like growth factor bioactivity and its modification in growth hormone resistant states. Baillieres Clin Endocrinol Metab 10: 421-446, 1996.
82. Dunne FP, Ratcliffe WA, Mansour P, Heath DA. Parathyroid hormone related protein (PTHrP) gene expression in fetal and extra-embryonic tissues of early pregnancy. Hum Reprod 9: 149-156, 1994.
83. Duvos C, Scutt A, Mayer H. hPTH-fragments (53- 84) and (28-48) antagonize the stimulation of calcium release and repression of alkaline phosphatase activity by hPTH-(1-34) in vitro. FEBS Lett 580: 1509-1514, 2006.
84. Ellis AG, Adam WR, Martin TJ. Comparison of the effects of parathyroid hormone (PTH) and recombinant PTH-related protein on bicarbonate excretion by the isolated perfused rat kidney. J Endocrinol 126: 403-408, 1990.
85. Ellison M, Woodhouse D, Hillyard C, Dowsett M, Coombes RC, Gilby ED, Greenberg PB, Neville AM. Immunoreactive calcitonin production by human lung carcinoma cells in culture. Br J Cancer 32: 373-379, 1975.
86. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet 12: 861-874, 2011.
87. Everhart-Caye M, Inzucchi SE, Guinness-Henry J, Mitnick MA, Stewart AF. Parathyroid hormone (PTH)-related protein(1-36) is equipotent to PTH(1-34) in humans. J Clin Endocrinol Metab 81: 199-208, 1996.
88. Fenton AJ, Kemp BE, Hammonds RG Jr, Mitchelhill K, Moseley JM, Martin TJ, Nicholson GC. A potent inhibitor of osteoclastic bone resorption within a highly conserved pentapeptide region of parathyroid hormone-related protein; PTHrP[107-111]. Endocrinology 129: 3424-3426, 1991.
89. Fenton AJ, Kemp BE, Kent GN, Moseley JM, Zheng MH, Rowe DJ, Britto JM, Martin TJ, Nicholson GC. A carboxyl-terminal peptide from the parathyroid hormone-related protein inhibits bone resorption by osteoclasts. Endocrinology 129: 1762-1768, 1991.
90. Fenton AJ, Martin TJ, Nicholson GC. Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139]. J Cell Physiol 155: 1-7, 1993.
91. Ferrandon S, Feinstein TN, Castro M, Wang B, Bouley R, Potts JT, Gardella TJ, Vilardaga JP. Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol 5: 734-742, 2009.
92. Finkelstein JS, Hayes A, Hunzelman JL, Wyland JJ, Lee H, Neer RM. The effects of parathyroid hormone, alendronate, or both in men with osteoporosis. N Engl J Med 349: 1216-1226, 2003.
93. Flanagan JA, Power DM, Bendell LA, Guerreiro PM, Fuentes J, Clark MS, Canario AV, Danks JA, Brown BL, Ingleton PM. Cloning of the cDNA for sea bream (Sparus aurata) parathyroid hormone-related protein. Gen Comp Endocrinol 118: 373-382, 2000.
94. Fleming NI, Trivett MK, George J, Slavin JL, Murray WK, Moseley JM, Anderson RL, Thomas DM. Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ. Cancer Res 69: 7473-7479, 2009.
95. Foley J, Longely BJ, Wysolmerski JJ, Dreyer BE, Broadus AE, Philbrick WM. PTHrP regulates epidermal differentiation in adult mice. J Invest Dermatol 111: 1122-1128, 1998.
96. Foley J, Wysolmerski JJ, Missero C, King CS, Philbrick WM. Regulation of parathyroid hormone-related protein gene expression in murine keratinocytes by E1A isoforms: a role for basal promoter and Ets-1 site. Mol Cell Endocrinol 156: 13-23, 1999.
97. Fox J, Miller MA, Stroup GB, Nemeth EF, Miller SC. Plasma levels of parathyroid hormone that induce anabolic effects in bone of ovariectomized rats can be achieved by stimulation of endogenous hormone secretion. Bone 21: 163-169, 1997.
98. Fraher LJ, Hodsman AB, Jonas K, Saunders D, Rose CI, Henderson JE, Hendy GN, Goltzman D. A comparison of the in vivo biochemical responses to exogenous parathyroid hormone-(1-34) [PTH-(1-34)] and PTH-related peptide-(1-34) in man. J Clin Endocrinol Metab 75: 417-423, 1992.
99. Frolik CA, Black EC, Cain RL, Satterwhite JH, Brown-Augsburger PL, Sato M, Hock JM. Anabolic and catabolic bone effects of human parathyroid hormone (1-34) are predicted by duration of hormone exposure. Bone 33: 372-379, 2003.
100. Frost HM. Dynamics of bone remodeling. Bone Biodynamics 315-333, 1964.
101. Garcia-Martin A, Ardura JA, Maycas M, Lozano D, Lopez-Herradon A, Portal-Nunez S, Garcia-Ocana A, Esbrit P. Functional roles of the nuclear localization signal of parathyroid hormone-related protein (PTHrP) in osteoblastic cells. Mol Endocrinol 28: 925-934, 2014.
102. Gardella TJ, Luck MD, Jensen GS, Schipani E, Potts JT Jr, Juppner H. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors. Endocrinology 137: 3936-3941, 1996.
103. Gardella TJ, Vilardaga JP. International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors-family B G protein-coupled receptors. Pharmacol Rev 67: 310-337, 2015.
104. Gensure RC, Gardella TJ, Juppner H. Parathyroid hormone and parathyroid hormone- related peptide, and their receptors. Biochem Biophys Res Commun 328: 666-678, 2005.
105. Gensure RC, Shimizu N, Tsang J, Gardella TJ. Identification of a contact site for residue 19 of parathyroid hormone (PTH) and PTH-related protein analogs in transmembrane domain two of the type 1 PTH receptor. Mol Endocrinol 17: 2647-2658, 2003.
106. Gesty-Palmer D, Chen M, Reiter E, Ahn S, Nelson CD, Wang S, Eckhardt AE, Cowan CL, Spurney RF, Luttrell LM, Lefkowitz RJ. Distinct beta-arrestin- and G proteindependent pathways for parathyroid hormone receptor-stimulated ERK1/2 activation. J Biol Chem 281: 10856-10864, 2006.
107. Gesty-Palmer D, Flannery P, Yuan L, Corsino L, Spurney R, Lefkowitz RJ, Luttrell LM. A beta-arrestin-biased agonist of the parathyroid hormone receptor (PTH1R) promotes bone formation independent of G protein activation. Sci Transl Med 1: 1ra1, 2009.
108. Goerdeladze J, Jablonski G, Paulssen R, Mortensen B, Gutvik K, Haug E, Rian E, Jemtland R, Friedman E, Bruland O. G-protein coupled signaling in osteosarcoma cell lines. In: Frontiers in Osteosarcoma Research, edited by Novak JF, McMaster JH. Seattle: Hogref and Huber, 1993, p. 297-308.
109. Goltzman D, Stewart AF, Broadus AE. Malignancy-associated hypercalcemia: evaluation with a cytochemical bioassay for parathyroid hormone. J Clin Endocrinol Metab 53: 899-904, 1981.
110. Goodrich LV, Johnson RL, Milenkovic L, McMahon JA, Scott MP. Conservation of the hedgehog/patched signaling pathway from flies to mice: induction of a mouse patched gene by Hedgehog. Genes Dev 10: 301-312, 1996.
111. Gooi JH, Pompolo S, Karsdal MA, Kulkarni NH, Kalajzic I, McAhren SH, Han B, Onyia JE, Ho PW, Gillespie MT, Walsh NC, Chia LY, Quinn JM, Martin TJ, Sims NA. Calcitonin impairs the anabolic effect of PTH in young rats and stimulates expression of sclerostin by osteocytes. Bone 46: 1486-1497, 2010.
112. Gowen M, Stroup GB, Dodds RA, James IE, Votta BJ, Smith BR, Bhatnagar PK, Lago AM, Callahan JF, DelMar EG, Miller MA, Nemeth EF, Fox J. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest 105: 1595-1604, 2000.
113. Greenberg PB, Martin TJ, Sutcliffe HS. Synthesis and release of parathyroid hormone by a renal carcinoma in cell culture. Clin Sci Mol Med 45: 183-191, 1973.
114. Grill V, Hillary J, Ho PM, Law FM, MacIsaac RJ, MacIsaac IA, Moseley JM, Martin TJ. Parathyroid hormone-related protein: a possible endocrine function in lactation. Clin Endocrinol 37: 405-410, 1992.
115. Grill V, Ho P, Body JJ, Johanson N, Lee SC, Kukreja SC, Moseley JM, Martin TJ. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer. J Clin Endocrinol Metab 73: 1309-1315, 1991.
116. Gu Z, Liu Y, Zhang Y, Jin S, Chen Q, Goltzman D, Karaplis A, Miao D. Absence of PTHrP nuclear localization and carboxyl terminus sequences leads to abnormal brain development and function. PLoS One 7: e41542, 2012.
117. Guenther HL, Hofstetter W, Moseley JM, Gillespie MT, Suda N, Martin TJ. Evidence for the synthesis of parathyroid hormone-related protein (PTHrP) by nontransformed clonal rat osteoblastic cells in vitro. Bone 16: 341-347, 1995.
118. Guise T. Examining the metastatic niche: targeting the microenvironment. Semin Oncol 37 Suppl 2: -S2-14, 2010.
119. Guo J, Chung UI, Kondo H, Bringhurst FR, Kronenberg HM. The PTH/PTHrP receptor can delay chondrocyte hypertrophy in vivo without activating phospholipase C. Dev Cell 3: 183-194, 2002.
120. Guo J, Liu M, Yang D, Bouxsein ML, Thomas CC, Schipani E, Bringhurst FR, Kronenberg HM. Phospholipase C signaling via the parathyroid hormone (PTH)/PTH-related peptide receptor is essential for normal bone responses to PTH. Endocrinology 151: 3502-3513, 2010.
121. Hammonds RG Jr, McKay P, Winslow GA, Diefenbach-Jagger H, Grill V, Glatz J, Rodda CP, Moseley JM, Wood WI, Martin TJ. Purification and characterization of recombinant human parathyroid hormone-related protein. J Biol Chem 264: 14806-14811, 1989.
122. Hattersley G, Dean T, Corbin BA, Bahar H, Gardella TJ. Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling. Endocrinology 157: 141-149, 2016.
123. Hattersley G, Lesage E, Varela A, Mith SY. BA058, a novel human PTHrP analog, restores bone mass in the aged, ovariectomized cynomolgus monkey. J Bone Miner Res 28 Suppl 1: 34, 2013.
124. Hattner R, Epker BN, Frost HM. Suggested sequential mode of control of changes in cell behaviour in adult bone remodelling. Nature 206: 489-490, 1965.
125. Heath JK, Southby J, Fukumoto S, O’Keeffe LM, Martin TJ, Gillespie MT. Epidermal growth factor-stimulated parathyroid hormone-related protein expression involves increased gene transcription and mRNA stability. Biochem J 307: 159-167, 1995.
126. Henderson JE, Amizuka N, Warshawsky H, Biasotto D, Lanske BM, Goltzman D, Karaplis AC. Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol 15: 4064-4075, 1995.
127. Henderson M, Danks J, Moseley J, Slavin J, Harris T, McKinlay M, Hopper J, Martin T. Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases. J Natl Cancer Inst 93: 234-237, 2001.
128. Henderson MA, Danks JA, Slavin JL, Byrnes GB, Choong PF, Spillane JB, Hopper JL, Martin TJ. Parathyroid hormone-related protein localization in breast cancers predict improved prognosis. Cancer Res 66: 2250-2256, 2006.
129. Hendy GN, Bennett HP, Gibbs BF, Lazure C, Day R, Seidah NG. Proparathyroid hormone is preferentially cleaved to parathyroid hormone by the prohormone convertase furin. A mass spectrometric study. J Biol Chem 270: 9517-9525, 1995.
130. Henry JG, Mitnick M, Dann PR, Stewart AF. Parathyroid hormone-related protein-(1-36) is biologically active when administered subcutaneously to humans. J Clin Endocrinol Metab 82: 900-906, 1997.
131. Ho PW, Goradia A, Russell MR, Chalk AM, Milley KM, Baker EK, Danks JA, Slavin JL, Walia M, Crimeen-Irwin B, Dickins RA, Martin TJ, Walkley CR. Knockdown of PTHR1 in osteosarcoma cells decreases invasion and growth and increases tumor differentiation in vivo. Oncogene 34: 2922-2933, 2015.
132. Hock JM, Fonseca J, Gunness-Hey M, Kemp BE, Martin TJ. Comparison of the anabolic effects of synthetic parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34 on bone in rats. Endocrinology 125: 2022-2027, 1989.
133. Horwitz MJ, Augustine M, Kahn L, Martin E, Oakley CC, Carneiro RM, Tedesco MB, Laslavic A, Sereika SM, Bisello A, Garcia-Ocana A, Gundberg CM, Cauley JA, Stewart AF. A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study. J Bone Miner Res 28: 2266-2276, 2013.
134. Horwitz MJ, Tedesco MB, Garcia-Ocana A, Sereika SM, Prebehala L, Bisello A, Hollis BW, Gundberg CM, Stewart AF. Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose. J Clin Endocrinol Metab 95: 1279-1287, 2010.
135. Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW, Garcia-Ocana A, Stewart AF. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25- dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. J Clin Endocrinol Metab 88: 1603-1609, 2003.
136. Horwitz MJ, Tedesco MB, Sereika SM, Prebehala L, Gundberg CM, Hollis BW, Bisello A, Garcia-Ocana A, Carneiro RM, Stewart AF. A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover. J Bone Miner Res 26: 2287-2297, 2011.
137. Huang W, Chung UI, Kronenberg HM, de Crombrugghe B. The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA 98: 160-165, 2001.
138. Ikeda K, Lu C, Weir EC, Mangin M, Broadus AE. Regulation of parathyroid hormonerelated peptide gene expression by cycloheximide. J Biol Chem 265: 5398-5402, 1990.
139. Ikeda K, Mangin M, Dreyer BE, Webb AC, Posillico JT, Stewart AF, Bander NH, Weir EC, Insogna KL, Broadus AE. Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malignancy. J Clin Invest 81: 2010-2014, 1988.
140. Imamura H, Sato K, Shizume K, Satoh T, Kasono K, Ozawa M, Ohmura E, Tsushima T, Demura H. Urinary excretion of parathyroid hormone-related protein fragments in patients with humoral hypercalcemia of malignancy and hypercalcemic tumorbearing nude mice. J Bone Miner Res 6: 77-84, 1991.
141. Ingleton PM, Underwood JC, Hunt NH, Atkins D, Giles B, Coulton LA, Martin TJ. Radiation induced osteogenic sarcoma in the rat as a model of hormone-responsive differentiated cancer. Lab Anim Sci 27: 748-756, 1977.
142. 2+ level and tension in rat aortic smooth muscle. Eur J Pharmacol 269: 311-317, 1994.
143. Iwamoto M, Enomoto-Iwamoto M, Kurisu K. Actions of hedgehog proteins on skeletal cells. Crit Rev Oral Biol Med 10: 477-486, 1999.
144. Jans DA. Nuclear signaling pathways for polypeptide ligands and their membrane receptors? FASEB J 8: 841-847, 1994.
145. Jans DA. The regulation of protein transport to the nucleus by phosphorylation. Biochem J 311: 705-716, 1995.
146. Jans DA, Ackermann MJ, Bischoff JR, Beach DH, Peters R. p34cdc2-mediated phosphorylation at T124 inhibits nuclear import of SV-40 T antigen proteins. J Cell Biol 115: 1203-1212, 1991.
147. Jans DA, Briggs LJ, Gustin SE, Jans P, Ford S, Young IG. The cytokine interleukin-5 (IL-5) effects cotransport of its receptor subunits to the nucleus in vitro. FEBS Lett 410: 368-372, 1997.
148. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF. Recombinant human parathyroid hormone (1-34) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res 18: 1932-1941, 2003.
149. Jilka RL. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 40: 1434-1446, 2007.
150. Jilka RL, Weinstein RS, Bellido T, Roberson P, Parfitt AM, Manolagas SC. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 104: 439-446, 1999.
151. John MR, Widler L, Gamse R, Buhl T, Seuwen K, Breitenstein W, Bruin GJ, Belleli R, Klickstein LB, Kneissel M. ATF936, a novel oral calcilytic, increases bone mineral density in rats and transiently releases parathyroid hormone in humans. Bone 49: 233-241, 2011.
152. Juppner H, Abou-Samra AB, Freeman M, Kong XF, Schipani E, Richards J, Kolakowski LF Jr, Hock J, Potts JT Jr, Kronenberg HM. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254: 1024-1026, 1991.
153. Kaji H, Sugimoto T, Kanatani M, Fukase M, Chihara K. Carboxyl-terminal peptides from parathyroid hormone-related protein stimulate osteoclast-like cell formation. Endocrinology 136: 842-848, 1995.
154. Kamesh N, Aradhyam GK, Manoj N. The repertoire of G protein-coupled receptors in the sea squirt Ciona intestinalis. BMC Evol Biol 8: 129, 2008.
155. Karaplis AC, He B, Nguyen MT, Young ID, Semeraro D, Ozawa H, Amizuka N. Inactivating mutation in the human parathyroid hormone receptor type 1 gene in Blomstrand chondrodysplasia. Endocrinology 139: 5255-5258, 1998.
156. Karaplis AC, Kronenberg HM. Physiological roles for parathyroid hormone-related protein: lessons from gene knockout mice. Vitam Horm 52: 177-193, 1996.
157. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VL, Kronenberg HM, Mulligan RC. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone- related peptide gene. Genes Dev 8: 277-289, 1994.
158. Karaplis AC, Vautour L. Parathyroid hormone-related peptide and the parathyroid hormone/parathyroid hormone-related peptide receptor in skeletal development. Curr Opin Nephrol Hypertens 6: 308-313, 1997.
159. Karaplis AC, Yasuda T, Hendy GN, Goltzman D, Banville D. Gene-encoding parathyroid hormone-like peptide: nucleotide sequence of the rat gene and comparison with the human homologue. Mol Endocrinol 4: 441-446, 1990.
160. Karp SJ, Schipani E, St-Jacques B, Hunzelman J, Kronenberg H, McMahon AP. Indian hedgehog coordinates endochondral bone growth and morphogenesis via parathyroid hormone related-protein-dependent and -independent pathways. Development 127: 543-548, 2000.
161. Karperien M, Farih-Sips H, Lowik CW, de Laat SW, Boonstra J, Defize LH. Expression of the parathyroid hormone-related peptide gene in retinoic acid-induced differentiation: involvement of ETS and Sp1. Mol Endocrinol 11: 1435-1448, 1997.
162. Karperien M, van Dijk TB, Hoeijmakers T, Cremers F, Abou-Samra AB, Boonstra J, de Laat SW, Defize LH. Expression pattern of parathyroid hormone/parathyroid hormone related peptide receptor mRNA in mouse postimplantation embryos indicates involvement in multiple developmental processes. Mech Dev 47: 29-42, 1994.
163. Kartsogiannis V, Moseley J, McKelvie B, Chou ST, Hards DK, Ng KW, Martin TJ, Zhou H. Temporal expression of PTHrP during endochondral bone formation in mouse and intramembranous bone formation in an in vivo rabbit model. Bone 21: 385-392, 1997.
164. Keklikoglou I, Koerner C, Schmidt C, Zhang JD, Heckmann D, Shavinskaya A, Allgayer H, Guckel B, Fehm T, Schneeweiss A, Sahin O, Wiemann S, Tschulena U. MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-kappaB and TGF-beta signaling pathways. Oncogene 31: 4150-4163, 2012.
165. Keller H, Kneissel M. SOST is a target gene for PTH in bone. Bone 37: 148-158, 2005.
166. Kemp BE, Moseley JM, Rodda CP, Ebeling PR, Wettenhall RE, Stapleton D, Diefenbach-Jagger H, Ure F, Michelangeli VP, Simmons HA. Parathyroid hormone-related protein of malignancy: active synthetic fragments. Science 238: 1568-1570, 1987.
167. Kent GN, Price RI, Gutteridge DH, Smith M, Allen JR, Bhagat CI, Barnes MP, Hickling CJ, Retallack RW, Wilson SG. Human lactation: forearm trabecular bone loss, increased bone turnover, and renal conservation of calcium and inorganic phosphate with recovery of bone mass following weaning. J Bone Miner Res 5: 361-369, 1990.
168. Khosla S, van Heerden JA, Gharib H, Jackson IT, Danks J, Hayman JA, Martin TJ. Parathyroid hormone-related protein and hypercalcemia secondary to massive mammary hyperplasia. N Engl J Med 322: 1157, 1990.
169. Kim SW, Pajevic PD, Selig M, Barry KJ, Yang JY, Shin CS, Baek WY, Kim JE, Kronenberg HM. Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts. J Bone Miner Res 27: 2075-2084, 2012.
170. Kiriyama T, Gillespie MT, Glatz JA, Fukumoto S, Moseley JM, Martin TJ. Transforming growth factor beta stimulation of parathyroid hormone-related protein (PTHrP): a paracrine regulator? Mol Cell Endocrinol 92: 55-62, 1993.
171. Klopocki E, Hennig BP, Dathe K, Koll R, de Ravel T, Baten E, Blom E, Gillerot Y, Weigel JF, Kruger G, Hiort O, Seemann P, Mundlos S. Deletion and point mutations of PTHLH cause brachydactyly type E. Am J Hum Genet 86: 434-439, 2010.
172. Kobayashi T, Soegiarto DW, Yang Y, Lanske B, Schipani E, McMahon AP, Kronenberg HM. Indian hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHrP. J Clin Invest 115: 1734-1742, 2005.
173. Kovacs CS. Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones. Physiol Rev 94: 1143-1218, 2014.
174. Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 18: 832-872, 1997.
175. Kovacs CS, Lanske B, Hunzelman JL, Guo J, Karaplis AC, Kronenberg HM. Parathyroid hormone-related peptide (PTHrP) regulates fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Natl Acad Sci USA 93: 15233-15238, 1996.
176. Kovacs CS, Manley NR, Moseley JM, Martin TJ, Kronenberg HM. Fetal parathyroids are not required to maintain placental calcium transport. J Clin Invest 107: 1007-1015, 2001.
177. Kozhemyakina E, Cohen T, Yao TP, Lazar AB. Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A/histone deacetylase 4/MEF2 pathway. Mol Cell Biol 29: 5751-5762, 2009.
178. Kronenberg HM. Developmental regulation of the growth plate. Nature 423: 332-336, 2003.
179. Kronenberg HM, Chung U. The parathyroid hormone-related protein and Indian hedgehog feedback loop in the growth plate. Novartis Found Symp 232: 144-152, 2001.
180. Kukreja SC, D’Anza JJ, Melton ME, Wimbiscus SA, Grill V, Martin TJ. Lack of effects of neutralization of parathyroid hormone-related protein on calcium homeostasis in neonatal mice. J Bone Miner Res 6: 1197-1201, 1991.
181. Kukreja SC, Shemerdiak WP, Lad TE, Johnson PA. Elevated nephrogenous cyclic AMP with normal serum parathyroid hormone levels in patients with lung cancer. J Clin Endocrinol Metab 51: 167-169, 1980.
182. Kuo PL, Liao SH, Hung JY, Huang MS, Hsu YL. MicroRNA-33a functions as a bone metastasis suppressor in lung cancer by targeting parathyroid hormone related protein. Biochim Biophys Acta 1830: 3756-3766, 2013.
183. Lafferty FW. Pseudohyperparathyroidism. Medicine 45: 247-260, 1966.
184. Lam MH, Briggs LJ, Hu W, Martin TJ, Gillespie MT, Jans DA. Importin beta recognizes parathyroid hormone-related protein with high affinity and mediates its nuclear import in the absence of importin alpha. J Biol Chem 274: 7391-7398, 1999.
185. Lam MH, House CM, Tiganis T, Mitchelhill KI, Sarcevic B, Cures A, Ramsay R, Kemp BE, Martin TJ, Gillespie MT. Phosphorylation at the cyclin-dependent kinases site (Thr85) of parathyroid hormone-related protein negatively regulates its nuclear localization. J Biol Chem 274: 18559-18566, 1999.
186. Lam MH, Hu W, Xiao CY, Gillespie MT, Jans DA. Molecular dissection of the importin beta1-recognized nuclear targeting signal of parathyroid hormone-related protein. Biochem Biophys Res Commun 282: 629-634, 2001.
187. Lam MH, Olsen SL, Rankin WA, Ho PW, Martin TJ, Gillespie MT, Moseley JM. PTHrP and cell division: expression and localization of PTHrP in a keratinocyte cell line (HaCaT) during the cell cycle. J Cell Physiol 173: 433-446, 1997.
188. Lam MH, Thomas RJ, Martin TJ, Gillespie MT, Jans DA. Nuclear and nucleolar localization of parathyroid hormone-related protein. Immunol Cell Biol 78: 395-402, 2000.
189. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LH, Ho C, Mulligan RC, Abou-Samra AB, Juppner H, Segre GV, Kronenberg HM. PTH/ PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273: 663-666, 1996.
190. Leder BZ, O’Dea LS, Zanchetta JR, Kumar P, Banks K, McKay K, Lyttle CR, Hattersley G. Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 100: 697-706, 2015.
191. Leder BZ, Tsai JN, Uihlein AV, Burnett-Bowie SA, Zhu Y, Foley K, Lee H, Neer RM. Two years of Denosumab and teriparatide administration in postmenopausal women with osteoporosis (The DATA Extension Study): a randomized controlled trial. J Clin Endocrinol Metab 99: 1694-1700, 2014.
192. Lee K, Deeds JD, Segre GV. Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology 136: 453-463, 1995.
193. Lee K, Lanske B, Karaplis AC, Deeds JD, Kohno H, Nissenson RA, Kronenberg HM, Segre GV. Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology 137: 5109-5118, 1996.
194. Li C, Chen M, Sang M, Liu X,WuW, Li B. Comparative genomic analysis and evolution of family-B G protein-coupled receptors from six model insect species. Gene 519: 1-12, 2013.
195. Li J, Karaplis AC, Huang DC, Siegel PM, Camirand A, Yang XF, Muller WJ, Kremer R. PTHrP drives breast tumor initiation, progression, and metastasis in mice and is a potential therapy target. J Clin Invest 121: 4655-4669, 2011.
196. Liapis H, Crouch EC, Grosso LE, Kitazawa S, Wick MR. Expression of parathyroidlike protein in normal, proliferative, and neoplastic human breast tissues. Am J Pathol 143: 1169-1178, 1993.
197. Liddle GW, Island DP, Ney RL, Nicholson WE, Shimizu N. Nonpituitary neoplasms and Cushing’s syndrome. Ectopic "adrenocorticotropin" produced by nonpituitary neoplasms as a cause of Cushing’s syndrome. Arch Intern Med 111: 471-475, 1963.
198. Lin PP, Pandey MK, Jin F, Raymond AK, Akiyama H, Lozano G. Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice. Carcinogenesis 30: 1789-1795, 2009.
199. Lindsay R, Cosman F, Zhou H, Bostrom MP, Shen VW, Cruz JD, Nieves JW, Dempster DW. A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide. J Bone Miner Res 21: 366-373, 2006.
200. Linglart A, Fryssira H, Hiort O, Holterhus PM, Perez de Nanclares G, Argente J, Heinrichs C, Kuechler A, Mantovani G, Leheup B, Wicart P, Chassot V, Schmidt D, Rubio-Cabezas O, Richter-Unruh A, Berrade S, Pereda A, Boros E, Munoz-Calvo MT, Castori M, Gunes Y, Bertrand G, Bougneres P, Clauser E, Silve C. PRKAR1A and PDE4D mutations cause acrodysostosis but two distinct syndromes with or without GPCR-signaling hormone resistance. J Clin Endocrinol Metab 97: E2328-2338, 2012.
201. Liu Y, Berendsen AD, Jia S, Lotinun S, Baron R, Ferrara N, Olsen BR. Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. J Clin Invest 122: 3101-3113, 2012.
202. Long F, Chung UI, Ohba S, McMahon J, Kronenberg HM, McMahon AP. Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 131: 1309-1318, 2004.
203. Long F, Zhang XM, Karp S, Yang Y, McMahon AP. Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. Development 128: 5099-5108, 2001.
204. Lozano D, Fernandez-de-Castro L, Portal-Nunez S, Lopez-Herradon A, Dapia S, Gomez-Barrena E, Esbrit P. The C-terminal fragment of parathyroid hormone-related peptide promotes bone formation in diabetic mice with low-turnover osteopaenia. Br J Pharmacol 162: 1424-1438, 2011.
205. Ma YL, Zeng Q, Donley DW, Ste-Marie LG, Gallagher JC, Dalsky GP, Marcus R, Eriksen EF. Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis. J Bone Miner Res 21: 855-864, 2006.
206. Maass PG, Rump A, Schulz H, Stricker S, Schulze L, Platzer K, Aydin A, Tinschert S, Goldring MB, Luft FC, Bahring S. A misplaced lncRNA causes brachydactyly in humans. J Clin Invest 122: 3990-4002, 2012.
207. Maass PG, Wirth J, Aydin A, Rump A, Stricker S, Tinschert S, Otero M, Tsuchimochi K, Goldring MB, Luft FC, Bahring S. A cis-regulatory site downregulates PTHLH in translocation t(8;12)(q13;p11.2) and leads to Brachydactyly Type E. Hum Mol Genet 19: 848-860, 2010.
208. Maes C, Kronenberg H. Bone development and remodeling. In: Endocrinology, edited by DeGroot L, Jamieson J. New York: Elsevier Saunders, 2010, p. 1038-1072.
209. Majeska RJ, Rodan SB, Rodan GA. Maintenance of parathyroid hormone response in clonal rat osteosarcoma lines. Exp Cell Res 111: 465-468, 1978.
210. Mamillapalli R, VanHouten J, Dann P, Bikle D, Chang W, Brown E, Wysolmerski J. Mammary-specific ablation of the calcium-sensing receptor during lactation alters maternal calcium metabolism, milk calcium transport, and neonatal calcium accrual. Endocrinology 154: 3031-3042, 2013.
211. Mamillapalli R, VanHouten J, Zawalich W, Wysolmerski J. Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormonerelated protein secretion in normal versus malignant breast cells. J Biol Chem 283: 24435-24447, 2008.
212. Mangin M, Ikeda K, Broadus AE. Structure of the mouse gene encoding parathyroid hormone-related peptide. Gene 95: 195-202, 1990.
213. Mangin M, Ikeda K, Dreyer BE, Broadus AE. Isolation and characterization of the human parathyroid hormone-like peptide gene. Proc Natl Acad Sci USA 86: 2408-2412, 1989.
214. Mangin M, Ikeda K, Dreyer BE, Milstone L, Broadus AE. Two distinct tumor-derived, parathyroid hormone-like peptides result from alternative ribonucleic acid splicing. Mol Endocrinol 2: 1049-1055, 1988.
215. Mangin M, Webb AC, Dreyer BE, Posillico JT, Ikeda K, Weir EC, Stewart AF, Bander NH, Milstone L, Barton DE. Identification of a cDNA encoding a parathyroid hormone- like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc Natl Acad Sci USA 85: 597-601, 1988.
216. Martin TJ. Osteoblast-derived PTHrP is a physiological regulator of bone formation. J Clin Invest 115: 2322-2324, 2005.
217. Martin TJ, Atkins DA. Biochemical regulators of bone resorption and their significance in cancer. Essays Med Biochem 4: 49-82, 1979.
218. Martin TJ, Ingleton PM, Underwood JC, Michelangeli VP, Hunt NH, Melick RA. Parathyroid hormone-responsive adenylate cyclase in induced transplantable osteogenic rat sarcoma. Nature 260: 436-438, 1976.
219. Martin TJ, Moseley JM. Mechanisms in the skeletal complications of breast cancer. Endocr Relat Cancer 7: 271-284, 2000.
220. Martin TJ, Moseley JM, Williams ED. Parathyroid hormone-related protein: hormone and cytokine. J Endocrinol 154 Suppl: S23-37, 1997.
221. Martin TJ, Rodan GA. Coupling of bone formation and resorption during bone remodeling. In: Osteoporosis, edited by Marcus FD, Kelsey J. London: Academic, 2001.
222. Martin TJ, Sims NA. Osteoclast-derived activity in the coupling of bone formation to resorption. Trends Mol Med 11: 76-81, 2005.
223. Martin TJ, Suva LJ. Parathyroid hormone-related protein in hypercalcaemia of malignancy. Clin Endocrinol 31: 631-647, 1989.
224. Marx SJ, Zusman RM, Umiker WO. Benign breast dysplasia causing hypercalcemia. J Clin Endocrinol Metab 45: 1049-1052, 1977.
225. Marx UC, Adermann K, Bayer P, Forssmann WG, Rosch P. Solution structures of human parathyroid hormone fragments hPTH(1-34) and hPTH(1-39) and bovine parathyroid hormone fragment bPTH(1-37). Biochem Biophys Res Commun 267: 213-220, 2000.
226. Marx UC, Adermann K, Bayer P, Meyer M, Forssmann WG, Rosch P. Structureactivity relation of NH2-terminal human parathyroid hormone fragments. J Biol Chem 273: 4308-4316, 1998.
227. Massfelder T, Dann P, Wu TL, Vasavada R, Helwig JJ, Stewart AF. Opposing mitogenic and anti-mitogenic actions of parathyroid hormone-related protein in vascular smooth muscle cells: a critical role for nuclear targeting. Proc Natl Acad Sci USA 94: 13630-13635, 1997.
228. Massfelder T, Fiaschi-Taesch N, Stewart AF, Helwig JJ. Parathyroid hormone-related peptide-a smooth muscle tone and proliferation regulatory protein. Curr Opin Nephrol Hypertens 7: 27-32, 1998.
229. Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet 5: e1000459, 2009.
230. Mavligit GM, Cohen JL, Sherwood LM. Ectopic production of parathyroid hormone by carcinoma of the breast. N Engl J Med 285: 154-156, 1971.
231. McCauley LK, Beecher CA, Melton ME, Werkmeister JR, Juppner H, Abou-Samra AB, Segre GV, Rosol TJ. Transforming growth factor-beta1 regulates steady-state PTH/ PTHrP receptor mRNA levels and PTHrP binding in ROS 17/2.8 osteosarcoma cells. Mol Cell Endocrinol 101: 331-336, 1994.
232. McCauley LK, Martin TJ. Twenty-five years of PTHrP progress: from cancer hormone to multifunctional cytokine. J Bone Miner Res 27: 1231-1239, 2012.
233. McMahon AP. More surprises in the Hedgehog signaling pathway. Cell 100: 185-188, 2000.
234. Meador CK, Liddle GW, Island DP, Nicholson WE, Lucas CP, Nuckton JG, Luetscher JA. Cause of Cushing’s syndrome in patients with tumors arising from "nonendocrine" tissue. J Clin Endocrinol Metab 22: 693-703, 1962.
235. Melick RA, Martin TJ, Hicks JD. Parathyroid hormone production and malignancy. Br Med J 2: 204-205, 1972.
236. Merryman JI, DeWille JW, Werkmeister JR, Capen CC, Rosol TJ. Effects of transforming growth factor-beta on parathyroid hormone-related protein production and ribonucleic acid expression by a squamous carcinoma cell line in vitro. Endocrinology 134: 2424-2430, 1994.
237. Miao D, He B, Jiang Y, Kobayashi T, Soroceanu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A, Genant HK, Kronenberg HM, Goltzman D, Karaplis AC. Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115: 2402-2411, 2005.
238. Miao D, He B, Karaplis AC, Goltzman D. Parathyroid hormone is essential for normal fetal bone formation. J Clin Invest 109: 1173-1182, 2002.
239. Miao D, Su H, He B, Gao J, Xia Q, Zhu M, Gu Z, Goltzman D, Karaplis AC. Severe growth retardation and early lethality in mice lacking the nuclear localization sequence and C-terminus of PTH-related protein. Proc Natl Acad Sci USA 105: 20309-20314, 2008.
240. Minagawa M, Yasuda T, Watanabe T, Minamitani K, Takahashi Y, Goltzman D, White JH, Hendy GN, Kohno Y. Association between AAAG repeat polymorphism in the P3 promoter of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene and adult height, urinary pyridinoline excretion, and promoter activity. J Clin Endocrinol Metab 87: 1791-1796, 2002.
241. Mok LL, Nickols GA, Thompson JC, Cooper CW. Parathyroid hormone as a smooth muscle relaxant. Endocr Rev 10: 420-436, 1989.
242. Molyneux SD, Di Grappa MA, Beristain AG, McKee TD, Wai DH, Paderova J, Kashyap M, Hu P, Maiuri T, Narala SR, Stambolic V, Squire J, Penninger J, Sanchez O, Triche TJ, Wood GA, Kirschner LS, Khokha R. Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice. J Clin Invest 120: 3310-3325, 2010.
243. Moniz C, Burton PB, Malik AN, Dixit M, Banga JP, Nicolaides K, Quirke P, Knight DE, McGregor AM. Parathyroid hormone-related peptide in normal human fetal development. J Mol Endocrinol 5: 259-266, 1990.
244. Moseley JM, Hayman JA, Danks JA, Alcorn D, Grill V, Southby J, Horton MA. Immunohistochemical detection of parathyroid hormone-related protein in human fetal epithelia. J Clin Endocrinol Metab 73: 478-484, 1991.
245. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall RE, Kemp BE, Suva LJ, Rodda CP, Ebeling PR, Hudson PJ, Zajac JD. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA 84: 5048-5052, 1987.
246. Murrills RJ, Stein LS, Dempster DW. Lack of significant effect of carboxyl-terminal parathyroid hormone-related peptide fragments on isolated rat and chick osteoclasts. Calcif Tissue Int 57: 47-51, 1995.
247. Mutsaers AJ, Ng AJ, Baker EK, Russell MR, Chalk AM, Wall M, Liddicoat BJ, Ho PW, Slavin JL, Goradia A, Martin TJ, Purton LE, Dickins RA, Walkley CR. Modeling distinct osteosarcoma subtypes in vivo using Cre: lox and lineage-restricted transgenic shRNA. Bone 55: 166-178, 2013.
248. Mutsaers AJ, Walkley CR. Cells of origin in osteosarcoma: mesenchymal stem cells or osteoblast committed cells? Bone 62: 56-63, 2014.
249. Nagai S, Okazaki M, Segawa H, Bergwitz C, Dean T, Potts JT Jr, Mahon MJ, Gardella TJ, Juppner H. Acute down-regulation of sodium-dependent phosphate transporter NPT2a involves predominantly the cAMP/PKA pathway as revealed by signalingselective parathyroid hormone analogs. J Biol Chem 286: 1618-1626, 2011.
250. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344: 1434-1441, 2001.
251. Ng KW, Romas E, Donnan L, Findlay DM. Bone biology. Baillieres Clin Endocrinol Metab 11: 1-22, 1997.
252. Nguyen M, He B, Karaplis A. Nuclear forms of parathyroid hormone-related peptide are translated from non-AUG start sites downstream from the initiator methionine. Endocrinology 142: 694-703, 2001.
253. Nishishita T, Okazaki T, Ishikawa T, Igarashi T, Hata K, Ogata E, Fujita T. A negative vitamin D response DNA element in the human parathyroid hormone-related peptide gene binds to vitamin D receptor along with Ku antigen to mediate negative gene regulation by vitamin D. J Biol Chem 273: 10901-10907, 1998.
254. Noda M, Takuwa Y, Katoh T, Kurokawa K. Mechanical force regulation of vascular parathyroid hormone-related peptide expression. Kidney Int Suppl 55: S154-155, 1996.
255. Nyby MD, Hino T, Berger ME, Ormsby BL, Golub MS, Brickman AS. Desensitization of vascular tissue to parathyroid hormone and parathyroid hormone-related protein. Endocrinology 136: 2497-2504, 1995.
256. Okano K, Pirola CJ, Wang HM, Forrester JS, Fagin JA, Clemens TL. Involvement of cell cycle and mitogen-activated pathways in induction of parathyroid hormone-related protein gene expression in rat aortic smooth muscle cells. Endocrinology 136: 1782-1789, 1995.
257. Oldenburg KR, Epand RF, D’Orfani A, Vo K, Selick H, Epand RM. Conformational studies on analogs of recombinant parathyroid hormone and their interactions with phospholipids. J Biol Chem 271: 17582-17591, 1996.
258. Ominsky MS, Libanati C, Niu QT, Boyce RW, Kostenuik PJ, Wagman RB, Baron R, Dempster DW. Sustained modeling-based bone formation during adulthood in cynomolgus monkeys may contribute to continuous BMD gains with denosumab. J Bone Miner Res 30: 1280-1289, 2015.
259. Orloff JJ, Ganz MB, Nathanson MH, Moyer MS, Kats Y, Mitnick M, Behal A, Gasalla-Herraiz J, Isales CM. A midregion parathyroid hormone-related peptide mobilizes cytosolic calcium and stimulates formation of inositol trisphosphate in a squamous carcinoma cell line. Endocrinology 137: 5376-5385, 1996.
260. Orloff JJ, Reddy D, de Papp AE, Yang KH, Soifer NE, Stewart AF. Parathyroid hormone- related protein as a prohormone: posttranslational processing and receptor interactions. Endocr Rev 15: 40-60, 1994.
261. Orloff JJ, Wu TL, Stewart AF. Parathyroid hormone-like proteins: biochemical responses and receptor interactions. Endocr Rev 10: 476-495, 1989.
262. Pache JC, Burton DW, Deftos LJ, Hastings RH. A carboxyl leucine-rich region of parathyroid hormone-related protein is critical for nuclear export. Endocrinology 147: 990-998, 2006.
263. Palmieri GM, Nordquist RE, Omenn GS. Immunochemical localization of parathyroid hormone in cancer tissue from patients with ectopic hyperparathyroidism. J Clin Invest 53: 1726-1735, 1974.
264. Parfitt AM. Skeletal heterogeneity and the purposes of bone remodelling: implications for the understanding of osteoporosis. In: Osteoporosis, edited by Marcus R, Feldman D, and Kelsey J. San Diego, CA: Academic, 1996, p. 315-339.
265. Partridge NC, Alcorn D, Michelangeli VP, Kemp BE, Ryan GB, Martin TJ. Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells. Endocrinology 108: 213-219, 1981.
266. Pasquini GM, Davey RA, Ho PW, Michelangeli VP, Grill V, Kaczmarczyk SJ, Zajac JD. Local secretion of parathyroid hormone-related protein by an osteoblastic osteosarcoma (UMR 106-01) cell line results in growth inhibition. Bone 31: 598-605, 2002.
267. Patterson EK, Watson PH, Hodsman AB, Hendy GN, Canaff L, Bringhurst FR, Poschwatta CH, Fraher LJ. Expression of PTH1R constructs in LLC-PK1 cells: protein nuclear targeting is mediated by the PTH1R NLS. Bone 41: 603-610, 2007.
268. Philbrick WM, Dreyer BE, Nakchbandi IA, Karaplis AC. Parathyroid hormone-related protein is required for tooth eruption. Proc Natl Acad Sci USA 95: 11846-11851, 1998.
269. Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, Yang KH, Vasavada RC, Weir EC, Broadus AE, Stewart AF. Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 76: 127-173, 1996.
270. Pioszak AA, Parker NR, Gardella TJ, Xu HE. Structural basis for parathyroid hormone- related protein binding to the parathyroid hormone receptor and design of conformation-selective peptides. J Biol Chem 284: 28382-28391, 2009.
271. Pirola CJ, Wang HM, Kamyar A, Wu S, Enomoto H, Sharifi B, Forrester JS, Clemens TL, Fagin JA. Angiotensin II regulates parathyroid hormone-related protein expression in cultured rat aortic smooth muscle cells through transcriptional and posttranscriptional mechanisms. J Biol Chem 268: 1987-1994, 1993.
272. Pirola CJ, Wang HM, Strgacich MI, Kamyar A, Cercek B, Forrester JS, Clemens TL, Fagin JA. Mechanical stimuli induce vascular parathyroid hormone-related protein gene expression in vivo and in vitro. Endocrinology 134: 2230-2236, 1994.
273. Plawner LL, Philbrick WM, Burtis WJ, Broadus AE, Stewart AF. Cell type-specific secretion of parathyroid hormone-related protein via the regulated versus the constitutive secretory pathway. J Biol Chem 270: 14078-14084, 1995.
274. Plotkin H, Gundberg C, Mitnick M, Stewart AF. Dissociation of bone formation from resorption during 2-week treatment with human parathyroid hormone-related peptide-(1-36) in humans: potential as an anabolic therapy for osteoporosis. J Clin Endocrinol Metab 83: 2786-2791, 1998.
275. Powell D, Singer FR, Murray TM, Minkin C, Potts JT Jr. Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases. N Engl J Med 289: 176-181, 1973.
276. Powell WF Jr, Barry KJ, Tulum I, Kobayashi T, Harris SE, Bringhurst FR, Pajevic PD. Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J Endocrinol 209: 21-32, 2011.
277. Power DM, Ingleton PM, Flanagan J, Canario AV, Danks J, Elgar G, Clark MS. Genomic structure and expression of parathyroid hormone-related protein gene (PTHrP) in a teleost, Fugu rubripes. Gene 250: 67-76, 2000.
278. Qian J, Lorenz JN, Maeda S, Sutliff RL, Weber C, Nakayama T, Colbert MC, Paul RJ, Fagin JA, Clemens TL. Reduced blood pressure and increased sensitivity of the vasculature to parathyroid hormone-related protein (PTHrP) in transgenic mice overexpressing the PTH/PTHrP receptor in vascular smooth muscle. Endocrinology 140: 1826-1833, 1999.
279. Qing H, Ardeshirpour L, Pajevic PD, Dusevich V, Jahn K, Kato S, Wysolmerski J, Bonewald LF. Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. J Bone Miner Res 27: 1018-1029, 2012.
280. Quist T, Jin H, Zhu JF, Smith-Fry K, Capecchi MR, Jones KB. The impact of osteoblastic differentiation on osteosarcomagenesis in the mouse. Oncogene 34: 4278-4284, 2015.
281. Rabbani SA, Haq M, Goltzman D. Biosynthesis and processing of endogenous parathyroid hormone related peptide (PTHRP) by rat Leydig cell tumor H-500. Biochemistry 32: 4931-4937, 1993.
282. Rakopoulos M, Vargas SJ, Gillespie MT, Ho PW, Diefenbach-Jagger H, Leaver DD, Grill V, Moseley JM, Danks JA, Martin TJ. Production of parathyroid hormone-related protein by the rat mammary gland in pregnancy and lactation. Am J Physiol Endocrinol Metab 263: E1077-E1085, 1992.
283. Ratcliffe WA, Thompson GE, Care AD, Peaker M. Production of parathyroid hormone- related protein by the mammary gland of the goat. J Endocrinol 133: 87-93, 1992.
284. Reeve J, Hesp R, Williams D, Hulme P, Klenerman L, Zanelli JM, Darby AJ, Tregear GW, Parsons JA. Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet 1: 1035-1038, 1976.
285. Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OL, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJ, Potts JT Jr. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 280: 1340-1344, 1980.
286. Riggs BL, Arnaud CD, Reynolds JC, Smith LH. Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancer. J Clin Invest 50: 2079-2083, 1971.
287. Rihani-Basharat S, Lewinson D. PTHrP(107-111) inhibits in vivo resorption that was stimulated by PTHrP(1-34) when applied intermittently to neonatal mice. Calcif Tissue Int 61: 426-428, 1997.
288. Rodan SB, Insogna KL, Vignery AM, Stewart AF, Broadus AE, D’Souza SM, Bertolini DR, Mundy GR, Rodan GA. Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells. J Clin Invest 72: 1511-1515, 1983.
289. Rodan SB, Wesolowski G, Ianacone J, Thiede MA, Rodan GA. Production of parathyroid hormone-like peptide in a human osteosarcoma cell line: stimulation by phorbol esters and epidermal growth factor. J Endocrinol 122: 219-227, 1989.
290. Rodda CP, Kubota M, Heath JA, Ebeling PR, Moseley JM, Care AD, Caple IW, Martin TJ. Evidence for a novel parathyroid hormone-related protein in fetal lamb parathyroid glands and sheep placenta: comparisons with a similar protein implicated in humoral hypercalcaemia of malignancy. J Endocrinol 117: 261-271, 1988.
291. Roof BS, Carpenter B, Fink DJ, Gordan GS. Some thoughts on the nature of ectopic parathyroid hormones. Am J Med 50: 686-691, 1971.
292. Rosol TJ, Steinmeyer CL, McCauley LK, Grone A, DeWille JW, Capen CC. Sequences of the cDNAs encoding canine parathyroid hormone-related protein and parathyroid hormone. Gene 160: 241-243, 1995.
293. Rude RK, Haussler MR, Singer FR. Postpartum resolution of hypocalcemia in a lactating hypoparathyroid patient. Endocrinol Jpn 31: 227-233, 1984.
294. Rude RK, Sharp CF Jr, Fredericks RS, Oldham SB, Elbaum N, Link J, Irwin L, Singer FR. Urinary and nephrogenous adenosine 3',5'-monophosphate in the hypercalcemia of malignancy. J Clin Endocrinol Metab 52: 765-771, 1981.
295. San Martin IA, Varela N, Gaete M, Villegas K, Osorio M, Tapia JC, Antonelli M, Mancilla EE, Pereira BP, Nathan SS, Lian JB, Stein JL, Stein GS, van Wijnen AJ, Galindo M. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells. J Cell Physiol 221: 560 -571, 2009.
296. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Butters RR, Brown EM. Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology 141: 4357-4364, 2000.
297. Sato M, Vahle J, Schmidt A, Westmore M, Smith S, Rowley E, Ma LY. Abnormal bone architecture and biomechanical properties with near-lifetime treatment of rats with PTH. Endocrinology 143: 3230-3242, 2002.
298. Schermer DT, Chan SD, Bruce R, Nissenson RA, Wood WI, Strewler GJ. Chicken parathyroid hormone-related protein and its expression during embryologic development. J Bone Miner Res 6: 149-155, 1991.
299. Schipani E, Kruse K, Juppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268: 98-100, 1995.
300. Schipani E, Langman CB, Parfitt AM, Jensen GS, Kikuchi S, Kooh SW, Cole WG, Juppner H. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen’s metaphyseal chondrodysplasia. N Engl J Med 335: 708-714, 1996.
301. Schipani E, Lanske B, Hunzelman J, Luz A, Kovacs CS, Lee K, Pirro A, Kronenberg HM, Juppner H. Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide. Proc Natl Acad Sci USA 94: 13689-13694, 1997.
302. Schluter K, Katzer C, Frischkopf K, Wenzel S, Taimor G, Piper HM. Expression, release, and biological activity of parathyroid hormone-related peptide from coronary endothelial cells. Circ Res 86: 946-951, 2000.
303. Seeman E, Delmas PD. Reconstructing the skeleton with intermittent parathyroid hormone. Trends Endocrinol Metab 12: 281-283, 2001.
304. Seeman E, Martin TJ. Co-administration of antiresorptive and anabolic agents: a missed opportunity. J Bone Miner Res 30: 753-764, 2015.
305. Sellers RS, Luchin AI, Richard V, Brena RM, Lima D, Rosol TJ. Alternative splicing of parathyroid hormone-related protein mRNA: expression and stability. J Mol Endocrinol 33: 227-241, 2004.
306. Selye H. On the stimulation of new bone formation with parathyroid extract and irradiated ergosterol. Endocrinology 16: 547-558, 1932.
307. Senior PV, Heath DA, Beck F. Expression of parathyroid hormone-related protein mRNA in the rat before birth: demonstration by hybridization histochemistry. J Mol Endocrinol 6: 281-290, 1991.
308. Shaw G, Kamen R. A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667, 1986.
309. Sherwood LM, O’Riordan JL, Aurbach GD, Potts JT Jr. Production of parathyroid hormone by nonparthyroid tumors. J Clin Endocrinol Metab 27: 140-146, 1967.
310. Silve C, Le-Stunff C, Motte E, Gunes Y, Linglart A, Clauser E. Acrodysostosis syndromes. Bonekey Rep 1: 225, 2012.
311. Sims NA, Martin TJ. Coupling signals between the osteoclast and osteoblast: how are messages transmitted between these temporary visitors to the bone surface? Front Endocrinol 6: 41, 2015.
312. Singh AT, Gilchrist A, Voyno-Yasenetskaya T, Radeff-Huang JM, Stern PH. G alpha12/ G alpha13 subunits of heterotrimeric G proteins mediate parathyroid hormone activation of phospholipase D in UMR-106 osteoblastic cells. Endocrinology 146: 2171-2175, 2005.
313. Smith MS, Grove KL. Integration of the regulation of reproductive function and energy balance: lactation as a model. Front Neuroendocrinol 23: 225-256, 2002.
314. Sneddon WB, Friedman PA. Beta-arrestin-dependent parathyroid hormone-stimulated extracellular signal-regulated kinase activation and parathyroid hormone type 1 receptor internalization. Endocrinology 148: 4073-4079, 2007.
315. Soifer NE, Dee KE, Insogna KL, Burtis WJ, Matovcik LM, Wu TL, Milstone LM, Broadus AE, Philbrick WM, Stewart AF. Parathyroid hormone-related protein. Evidence for secretion of a novel mid-region fragment by three different cell types. J Biol Chem 267: 18236-18243, 1992.
316. Sone T, Kohno H, Kikuchi H, Ikeda T, Kasai R, Kikuchi Y, Takeuchi R, Konishi J, Shigeno C. Human parathyroid hormone-related peptide-(107-111) does not inhibit bone resorption in neonatal mouse calvariae. Endocrinology 131: 2742-2746, 1992.
317. Southby J, Murphy LM, Martin TJ, Gillespie MT. Cell-specific and regulator-induced promoter usage and messenger ribonucleic acid splicing for parathyroid hormonerelated protein. Endocrinology 137: 1349-1357, 1996.
318. Southby J, O’Keeffe LM, Martin TJ, Gillespie MT. Alternative promoter usage and mRNA splicing pathways for parathyroid hormone-related protein in normal tissues and tumours. Br J Cancer 72: 702-707, 1995.
319. Sowers MF, Hollis BW, Shapiro B, Randolph J, Janney CA, Zhang D, Schork A, Crutchfield M, Stanczyk F, Russell-Aulet M. Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA 276: 549-554, 1996.
320. St-Jacques B, Hammerschmidt M, McMahon AP. Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev 13: 2072-2086, 1999.
321. Sterling JA, Edwards JR, Martin TJ, Mundy GR. Advances in the biology of bone metastasis: how the skeleton affects tumor behavior. Bone 48: 6-15, 2011.
322. Stewart AF. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton. J Bone Miner Res 17: 758-762, 2002.
323. Stewart AF, Cain RL, Burr DB, Jacob D, Turner CH, Hock JM. Six-month daily administration of parathyroid hormone and parathyroid hormone-related protein peptides to adult ovariectomized rats markedly enhances bone mass and biomechanical properties: a comparison of human parathyroid hormone 1-34, parathyroid hormone- related protein 1-36, and SDZ-parathyroid hormone 893. J Bone Miner Res 15: 1517-1525, 2000.
324. Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, Broadus AE. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups. N Engl J Med 303: 1377-1383, 1980.
325. Stewart AF, Insogna KL, Goltzman D, Broadus AE. Identification of adenylate cyclasestimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy. Proc Natl Acad Sci USA 80: 1454-1458, 1983.
326. Stewart AF, Wu T, Goumas D, Burtis WJ, Broadus AE. N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains. Biochem Biophys Res Commun 146: 672-678, 1987.
327. Strewler GJ, Stern PH, Jacobs JW, Eveloff J, Klein RF, Leung SC, Rosenblatt M, Nissenson RA. Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest 80: 1803-1807, 1987.
328. Strewler GJ, Williams RD, Nissenson RA. Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors. J Clin Invest 71: 769-774, 1983.
329. Suda N, Gillespie MT, Traianedes K, Zhou H, Ho PW, Hards DK, Allan EH, Martin TJ, Moseley JM. Expression of parathyroid hormone-related protein in cells of osteoblast lineage. J Cell Physiol 166: 94-104, 1996.
330. Suva LJ, Freeman AN, Martin TJ. Parathroid hormone-related proyein: gene structure, biosynthesis, metabolism and regulation. In: The Parathyroids, edited by Bilezikian JP. London: Academic, 2015, p. 45-64.
331. Suva LJ, Mather KA, Gillespie MT, Webb GC, Ng KW, Winslow GA, Wood WI, Martin TJ, Hudson PJ. Structure of the 5' flanking region of the gene encoding human parathyroid- hormone-related protein (PTHrP). Gene 77: 95-105, 1989.
332. Suva LJ, Seedor JG, Endo N, Quartuccio HA, Thompson DD, Bab I, Rodan GA. Pattern of gene expression following rat tibial marrow ablation. J Bone Miner Res 8: 379-388, 1993.
333. Suva LJ, Winslow GA, Wettenhall RE, Hammonds RG, Moseley JM, Diefenbach-Jagger H, Rodda CP, Kemp BE, Rodriguez H, Chen EY. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science 237: 893-896, 1987.
334. Syme CA, Friedman PA, Bisello A. Parathyroid hormone receptor trafficking contributes to the activation of extracellular signal-regulated kinases but is not required for regulation of cAMP signaling. J Biol Chem 280: 11281-11288, 2005.
335. Takasu H, Baba H, Inomata N, Uchiyama Y, Kubota N, Kumaki K, Matsumoto A, Nakajima K, Kimura T, Sakakibara S, Fujita T, Chihara K, Nagai I. The 69-84 amino acid region of the parathyroid hormone molecule is essential for the interaction of the hormone with the binding sites with carboxyl-terminal specificity. Endocrinology 137: 5537-5543, 1996.
336. Tang Y, Wu X, Lei W, Pang L, Wan C, Shi Z, Zhao L, Nagy TR, Peng X, Hu J, Feng X, Van Hul W, Wan M, Cao X. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat Med 15: 757-765, 2009.
337. Tashjian AH Jr, Gagel RF. Teriparatide [human PTH(1-34)]: 25 years of experience on the use and safety of the drug for the treatment of osteoporosis. J Bone Miner Res 21: 354-365, 2006.
338. Tashjian AH Jr, Goltzman D. On the interpretation of rat carcinogenicity studies for human PTH(1-34) and human PTH(1-84). J Bone Miner Res 23: 803-811, 2008.
339. Tashjian AH Jr, Levine L, Munson PL. Immunochemical identification of parathyroid hormone in non-parathyroid neoplasms associated with hypercalcemia. J Exp Med 119: 467-484, 1964.
340. Tazawa K, Hoshi K, Kawamoto S, Tanaka M, Ejiri S, Ozawa H. Osteocytic osteolysis observed in rats to which parathyroid hormone was continuously administered. J Bone Miner Metab 22: 524-529, 2004.
341. Teti A, Zallone A. Do osteocytes contribute to bone mineral homeostasis? Osteocytic osteolysis revisited. Bone 44: 11-16, 2009.
342. Thiede MA, Rodan GA. Expression of a calcium-mobilizing parathyroid hormone-like peptide in lactating mammary tissue. Science 242: 278-280, 1988.
343. Thiede MA, Strewler GJ, Nissenson RA, Rosenblatt M, Rodan GA. Human renal carcinoma expresses two messages encoding a parathyroid hormone-like peptide: evidence for the alternative splicing of a single-copy gene. Proc Natl Acad Sci USA 85: 4605-4609, 1988.
344. Thorikay M, Kramer S, Reynolds FH, Sorvillo JM, Doescher L, Wu T, Morris CA, Burtis WJ, Insogna KL, Valenzuela DM. Synthesis of a gene encoding parathyroid hormone-like protein-(1-141): purification and biological characterization of the expressed protein. Endocrinology 124: 111-118, 1989.
345. Toribio RE, Brown HA, Novince CM, Marlow B, Hernon K, Lanigan LG, Hildreth BE, 3rd Werbeck JL, Shu ST, Lorch G, Carlton M, Foley J, Boyaka P, McCauley LK, Rosol TJ. The midregion, nuclear localization sequence, and C terminus of PTHrP regulate skeletal development, hematopoiesis, and survival in mice. FASEB J 24: 1947-1957, 2010.
346. Tov AB, Mandel D, Weissman Y, Dollberg S, Taxir T, Lubetzky R. Changes in serum parathyroid hormone-related protein in breastfed preterm infants. Breastfeed Med 7: 50-53, 2012.
347. Tregear GW, Potts JT Jr. Synthetic analogues of residues 1-34 of human parathyroid hormone: influence of residue number 1 on biological potency in vitro. Endocr Res Commun 2: 561-570, 1975.
348. Tricoli JV, Rall LB, Scott J, Bell GI, Shows TB. Localization of insulin-like growth factor genes to human chromosomes 11 and 12. Nature 310: 784-786, 1984.
349. Trivett MK, Officer RA, Clement JG, Walker TI, Joss JM, Ingleton PM, Martin TJ, Danks JA. Parathyroid hormone-related protein (PTHrP) in cartilaginous and bony fish tissues. J Exp Zool 284: 541-548, 1999.
350. Truant R, Cullen BR. The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol Cell Biol 19: 1210-1217, 1999.
351. Tsai JN, Uihlein AV, Lee H, Kumbhani R, Siwila-Sackman E, McKay EA, Burnett-Bowie SA, Neer RM, Leder BZ. Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial. Lancet 382: 50-56, 2013.
352. Tsukazaki T, Ohtsuru A, Enomoto H, Yano H, Motomura K, Ito M, Namba H, Iwasaki K, Yamashita S. Expression of parathyroid hormone-related protein in rat articular cartilage. Calcif Tissue Int 57: 196-200, 1995.
353. Tucci J, Russell A, Senior PV, Fernley R, Ferraro T, Beck F. The expression of parathyroid hormone and parathyroid hormone-related protein in developing rat parathyroid glands. J Mol Endocrinol 17: 149-157, 1996.
354. Urena P, Kong XF, Abou-Samra AB, Juppner H, Kronenberg HM, Potts JT Jr, Segre GV. Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 133: 617-623, 1993.
355. Usdin TB, Wang T, Hoare SR, Mezey E, Palkovits M. New members of the parathyroid hormone/parathyroid hormone receptor family: the parathyroid hormone 2 receptor and tuberoinfundibular peptide of 39 residues. Front Neuroendocrinol 21: 349-383, 2000.
356. Vahle JL, Long GG, Sandusky G, Westmore M, Ma YL, Sato M. Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose. Toxicol Pathol 32: 426-438, 2004.
357. Valin A, Garcia-Ocana A, De Miguel F, Sarasa JL, Esbrit P. Antiproliferative effect of the C-terminal fragments of parathyroid hormone-related protein, PTHrP-(107-111) and (107-139), on osteoblastic osteosarcoma cells. J Cell Physiol 170: 209-215, 1997.
358. 2+ through a receptor different from the type 1 PTH/PTHrP receptor in osteoblastic osteosarcoma UMR 106 cells. Endocrinology 142: 2752-2759, 2001.
359. Van de Stolpe A, Karperien M, Lowik CW, Juppner H, Segre GV, Abou-Samra AB, de Laat SW, Defize LH. Parathyroid hormone-related peptide as an endogenous inducer of parietal endoderm differentiation. J Cell Biol 120: 235-243, 1993.
360. Van Heerden JA, Gharib H, Jackson IT. Pseudohyperparathyroidism secondary to gigantic mammary hypertrophy. Arch Surg 123: 80-82, 1988.
361. VanHouten J, Dann P, McGeoch G, Brown EM, Krapcho K, Neville M, Wysolmerski JJ. The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport. J Clin Invest 113: 598-608, 2004.
362. VanHouten JN, Dann P, Stewart AF, Watson CJ, Pollak M, Karaplis AC, Wysolmerski JJ. Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. J Clin Invest 112: 1429-1436, 2003.
363. VanHouten JN, Wysolmerski JJ. Low estrogen and high parathyroid hormone-related peptide levels contribute to accelerated bone resorption and bone loss in lactating mice. Endocrinology 144: 5521-5529, 2003.
364. Vasavada RC, Wysolmerski JJ, Broadus AE, Philbrick WM. Identification and characterization of a GC-rich promoter of the human parathyroid hormone-related peptide gene. Mol Endocrinol 7: 273-282, 1993.
365. Vilardaga JP, Gardella TJ, Wehbi VL, Feinstein TN. Non-canonical signaling of the PTH receptor. Trends Pharmacol Sci 33: 423-431, 2012.
366. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ. Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273: 613-622, 1996.
367. Walkley CR, Qudsi R, Sankaran VG, Perry JA, Gostissa M, Roth SI, Rodda SJ, Snay E, Dunning P, Fahey FH, Alt FW, McMahon AP, Orkin SH. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease. Genes Dev 22: 1662-1676, 2008.
368. Wallis GA. Bone growth: coordinating chondrocyte differentiation. Curr Biol 6: 1577-1580, 1996.
369. Walsh CA, Birch MA, Fraser WD, Lawton R, Dorgan J, Walsh S, Sansom D, Beresford JN, Gallagher JA. Expression and secretion of parathyroid hormone-related protein by human bone-derived cells in vitro: effects of glucocorticoids. J Bone Miner Res 10: 17-25, 1995.
370. Wang M, Nasiri AR, Broadus AE, Tommasini SM. Periosteal PTHrP regulates cortical bone remodeling during fracture healing. Bone 81: 104-111, 2015.
371. Wang M, VanHouten JN, Nasiri AR, Tommasini SM, Broadus AE. Periosteal PTHrP regulates cortical bone modeling during linear growth in mice. J Anat 225: 71-82, 2014.
372. Washam CL, Byrum SD, Leitzel K, Ali SM, Tackett AJ, Gaddy D, Sundermann SE, Lipton A, Suva LJ. Identification of PTHrP(12-48) as a plasma biomarker associated with breast cancer bone metastasis. Cancer Epidemiol Biomarkers Prev 22: 972-983, 2013.
373. Watson PH, Fraher LJ, Hendy GN, Chung UI, Kisiel M, Natale BV, Hodsman AB. Nuclear localization of the type 1 PTH/PTHrP receptor in rat tissues. J Bone Miner Res 15: 1033-1044, 2000.
374. Watson PH, Fraher LJ, Natale BV, Kisiel M, Hendy GN, Hodsman AB. Nuclear localization of the type 1 parathyroid hormone/parathyroid hormone-related peptide receptor in MC3T3-E1 cells: association with serum-induced cell proliferation. Bone 26: 221-225, 2000.
375. Weir EC, Burtis WJ, Morris CA, Brady TG, Insogna KL. Isolation of 16,000-dalton parathyroid hormone-like proteins from two animal tumors causing humoral hypercalcemia of malignancy. Endocrinology 123: 2744-2751, 1988.
376. Weir EC, Philbrick WM, Amling M, Neff LA, Baron R, Broadus AE. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci USA 93: 10240-10245, 1996.
377. Weiss A, Khoury JD, Hoffer FA, Wu J, Billups CA, Heck RK, Quintana J, Poe D, Rao BN, Daw NC. Telangiectatic osteosarcoma: the St Jude Children’s Research Hospital’s experience. Cancer 109: 1627-1637, 2007.
378. Werkmeister JR, Blomme EA, Weckmann MT, Grone A, McCauley LK, Wade AB, O’Rourke J, Capen CC, Rosol TJ. Effect of transforming growth factor-beta1 on parathyroid hormone-related protein secretion and mRNA expression by normal human keratinocytes in vitro. Endocrine 8: 291-299, 1998.
379. Williams SR, Aldred MA, Der Kaloustian VM, Halal F, Gowans G, McLeod DR, Zondag S, Toriello HV, Magenis RE, Elsea SH. Haploinsufficiency of HDAC4 causes brachydactyly mental retardation syndrome, with brachydactyly type E, developmental delays, and behavioral problems. Am J Hum Genet 87: 219-228, 2010.
380. Wills MR. Value of plasma chloride concentration and acid-base status in the differential diagnosis of hyperparathyroidism from other causes of hypercalcaemia. J Clin Pathol 24: 219-227, 1971.
381. Wojcik SF, Schanbacher FL, McCauley LK, Zhou H, Kartsogiannis V, Capen CC, Rosol TJ. Cloning of bovine parathyroid hormone-related protein (PTHrP) cDNA and expression of PTHrP mRNA in the bovine mammary gland. J Mol Endocrinol 20: 271-280, 1998.
382. Wu TL, Soifer NE, Burtis WJ, Milstone LM, Stewart AF. Glycosylation of parathyroid hormone-related peptide secreted by human epidermal keratinocytes. J Clin Endocrinol Metab 73: 1002-1007, 1991.
383. WuTL, Vasavada RC, Yang K, Massfelder T, Ganz M, Abbas SK, Care AD, Stewart AF. Structural and physiologic characterization of the mid-region secretory species of parathyroid hormone-related protein. J Biol Chem 271: 24371-24381, 1996.
384. Wysolmerski JJ, Cormier S, Philbrick WM, Dann P, Zhang JP, Roume J, Delezoide AL, Silve C. Absence of functional type 1 parathyroid hormone (PTH)/PTH-related protein receptors in humans is associated with abnormal breast development and tooth impaction. J Clin Endocrinol Metab 86: 1788-1794, 2001.
385. Wysolmerski JJ, Philbrick WM, Dunbar ME, Lanske B, Kronenberg H, Broadus AE. Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. Development 125: 1285-1294, 1998.
386. Wysolmerski JJ, Stewart AF, Kovacs CS. Physiological actions of PTH and PTHrP; epidermal, mammary, reproductive, pancreatic tissues. In: Principles of Bone Biology, edited by Bilezikian JP, Raisz LG, Martin TJ. New York: Academic, 2008, p. 713-731.
387. Xian L,WuX, Pang L, Lou M, Rosen CJ, Qiu T, Crane J, Frassica F, Zhang L, Rodriguez JP, Xiaofeng J, Shoshana Y, Shouhong X, Argiris E, Mei W, Cao X. Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells. Nat Med 18: 1095-1101, 2012.
388. Xiao W, Mohseny AB, Hogendoorn PC, Cleton-Jansen AM. Mesenchymal stem cell transformation and sarcoma genesis. Clin Sarcoma Res 3: 10, 2013.
389. Yamamoto M, Duong LT, Fisher JE, Thiede MA, Caulfield MP, Rosenblatt M. Sucklingmediated increases in urinary phosphate and 3',5'-cyclic adenosine monophosphate excretion in lactating rats: possible systemic effects of parathyroid hormone-related protein. Endocrinology 129: 2614-2622, 1991.
390. Yamamoto M, Harm SC, Grasser WA, Thiede MA. Parathyroid hormone-related protein in the rat urinary bladder: a smooth muscle relaxant produced locally in response to mechanical stretch. Proc Natl Acad Sci USA 89: 5326-5330, 1992.
391. Yang D, Singh R, Divieti P, Guo J, Bouxsein ML, Bringhurst FR. Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolic effect of PTH on bone. Bone 40: 1453-1461, 2007.
392. Yang KH, dePapp AE, Soifer NE, Dreyer BE, Wu TL, Porter SE, Bellantoni M, Burtis WJ, Insogna KL, Broadus AE. Parathyroid hormone-related protein: evidence for isoform- and tissue-specific posttranslational processing. Biochemistry 33: 7460-7469, 1994.
393. Yang R, Hoang BH, Kubo T, Kawano H, Chou A, Sowers R, Huvos AG, Meyers PA, Healey JH, Gorlick R. Over-expression of parathyroid hormone Type 1 receptor confers an aggressive phenotype in osteosarcoma. Int J Cancer 121: 943-954, 2007.
394. Yasuda T, Banville D, Hendy GN, Goltzman D. Characterization of the human parathyroid hormone-like peptide gene. Functional and evolutionary aspects. J Biol Chem 264: 7720-7725, 1989.
395. Zajac JD, Callaghan J, Eldridge C, Diefenbach-Jagger H, Suva LJ, Hudson P, Moseley JM, Michelangeli VP, Pasquini G. Production of parathyroid hormone-related protein by a rat parathyroid cell line. Mol Cell Endocrinol 67: 107-112, 1989.
396. Zhang P, Jobert AS, Couvineau A, Silve C. A homozygous inactivating mutation in the parathyroid hormone/parathyroid hormone-related peptide receptor causing Blomstrand chondrodysplasia. J Clin Endocrinol Metab 83: 3365-3368, 1998.
397. Zhu Q, Zhou X, Zhu M, Wang Q, Goltzman D, Karaplis A, Miao D. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation. J Bone Miner Res 28: 1898-1911, 2013.